Ex-Ru­bius CEO dusts him­self off at a dif­fer­ent Flag­ship biotech; Hutchmed switch­es things up dur­ing pipeline re­fo­cus

→ We led off Peer Re­view two weeks ago with what re­mains of Ru­bius Ther­a­peu­tics — and it’s not much. But ex-CEO Pablo Cagnoni has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.